Daily Newsletter

21 November 2023

Daily Newsletter

21 November 2023

Philips and Vestre Viken sign agreement for AI-powered platform

The AI application automatically identifies scans without immediate evidence of fractures.

November 21 2023

Philips has entered a framework agreement with Vestre Viken Health Trust in Norway to deploy an artificial intelligence (AI)-enabled clinical applications platform to enhance radiology services.

The deployment includes the cloud-based platform, Philips AI Manager, which incorporates an AI-based bone fracture radiology application.

The AI application automatically identifies scans without immediate evidence of fractures, allowing radiologists to focus on more complex cases.

Philips AI Manager expands clinical radiology applications that include intelligent algorithms, image processing, advanced visualisation and AI.

This is expected to reduce radiologists' workload, enhance patient outcomes, and streamline the diagnosis and treatment process for bone fractures.

Philips Clinical Informatics business leader Martijn Hartjes said: “There is a pressing need to ease the burden on radiologists.

“By incorporating AI into our clinical applications and expanding access to third-party AI with an end-to-end platform, we help radiologists to be faster and more efficient, reducing routine work and offering advanced diagnostic support, leading to better clinical outcomes and patient care.”

The technology will help patients across 22 municipalities, serving around half a million people.

The four-year agreement, with possible extension, claims to have the potential to reach 70% of the Norwegian population across 30 hospitals, representing the comprehensive enterprise-wide AI deployment in European healthcare.

Philips AI Manager is a cloud-based solution that integrates with various AI applications, including third-party offerings, to support radiology departments in managing high-volume workloads efficiently.

In addition, it expands the application of AI in radiology, cardiology, and neuroradiology.

Vestre Viken Health Trust technology director Cecilie Løken said: “Applying AI in our Radiology Department has surpassed our expectations.

“Besides improving patient flows, and quality of care to our patients, we have found that AI even finds fractures that doctors overlooked.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close